GLOW

GLOW 70 mg is Prime Time Bio Labs' research blend combining three listed peptides — GHK-Cu, BPC-157, and TB-500 — in a single vial totaling 70 mg. Prime Time Bio Labs does not publish a per-component breakdown on this page; the 70 mg figure refers to the vial's total peptide content, not to each listed peptide individually. The vial ships as a single-use, lyophilized (freeze-dried) powder, sealed and light-protected to preserve peptide integrity during shipping and storage. Each vial carries a lot-specific label so researchers can match their unit to its Certificate of Analysis. GLOW is distributed exclusively for qualified laboratory and in-vitro research use. It is not evaluated or approved by the FDA, is not intended for human or animal consumption, and should be handled only by trained personnel in a research setting.

GLOW combines three peptides that each have an independent research history. The notes below describe what has been studied about each component — they do not describe research on Prime Time Bio Labs' finished GLOW formulation, which has not itself been the subject of any independently verifiable study. No synergistic, combined, or enhanced effect from studying these three peptides together should be inferred. GHK-Cu. GHK-Cu is a naturally occurring copper-binding tripeptide. Laboratory research — including cell-culture and some randomized topical-formulation studies — has examined its association with collagen and elastin synthesis, fibroblast activity, and angiogenesis-related signaling in skin tissue. Most of the strongest human data relates to topical cosmetic formulations rather than injectable research-grade material, and evidence at research-grade purity and format has not been separately established. BPC-157. BPC-157 is a synthetic peptide with an extensive preclinical literature — chiefly rodent studies — examining its association with tissue and gastrointestinal healing pathways. Human evidence remains limited to a small number of pilot-scale studies; no large randomized controlled human trial has been published for any indication, and BPC-157 is not FDA-approved. TB-500. TB-500 is marketed as a synthetic peptide related to thymosin beta-4, a naturally occurring protein studied for its role in cell migration and actin regulation. Published sources describe "TB-500" inconsistently — some identify it as a short synthetic fragment of thymosin beta-4, others as the full-length protein — and Prime Time Bio Labs' own documentation does not specify which form is used in this product. Direct human efficacy data for TB-500 specifically (as opposed to the parent protein) is not established, and it is not FDA-approved. On the blend itself. GHK-Cu, BPC-157, and TB-500 have each appeared, individually, in published laboratory or preclinical research. That is different from evidence that the combination — as formulated in GLOW — produces any particular effect. Prime Time Bio Labs does not present GLOW as clinically or scientifically validated as a finished blend.

Each lot of GLOW 70 mg is third-party tested for purity, identity, and sterility before Prime Time Bio Labs makes it available for sale. The current batch (PTBL08312026) reports 99% purity as analyzed on 9/2/2026; this figure reflects that specific batch and testing date, not a blanket guarantee across all future lots. The downloadable Certificate of Analysis lets researchers confirm the purity, identity, and lot number of the exact vial they receive against Prime Time Bio Labs' documentation. Purity, identity, and sterility testing establish the chemical composition and cleanliness of the material tested — they do not establish biological activity, safety, or effectiveness for any use, and should not be read as evidence supporting human or animal application.

GLOW 70 mg is sold strictly for laboratory and in-vitro research use by qualified professionals. It is not a drug, dietary supplement, or cosmetic, and it is not intended for human or animal consumption, diagnosis, or therapeutic use of any kind. It carries no FDA approval. By purchasing, researchers confirm the product will be used only within a qualified research setting consistent with this restriction.